- Home
- RDHL vs ONFO Comparison
RDHL vs ONFO Comparison
Compare RDHL & ONFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDHL
- ONFO
- Stock Information
- Founded
- RDHL 2009
- ONFO 2018
- Country
- RDHL Israel
- ONFO United States
- Employees
- RDHL N/A
- ONFO N/A
- Industry
- RDHL Biotechnology: Pharmaceutical Preparations
- ONFO Computer Software: Programming Data Processing
- Sector
- RDHL Health Care
- ONFO Technology
- Exchange
- RDHL Nasdaq
- ONFO Nasdaq
- Market Cap
- RDHL 6.8M
- ONFO 6.2M
- IPO Year
- RDHL N/A
- ONFO 2022
- Fundamental
- Price
- RDHL $2.45
- ONFO $0.93
- Analyst Decision
- RDHL
- ONFO
- Analyst Count
- RDHL 0
- ONFO 0
- Target Price
- RDHL N/A
- ONFO N/A
- AVG Volume (30 Days)
- RDHL 121.9K
- ONFO 31.1K
- Earning Date
- RDHL 04-11-2025
- ONFO 05-20-2025
- Dividend Yield
- RDHL N/A
- ONFO N/A
- EPS Growth
- RDHL N/A
- ONFO N/A
- EPS
- RDHL N/A
- ONFO N/A
- Revenue
- RDHL $3,707,000.00
- ONFO $6,590,171.00
- Revenue This Year
- RDHL $224.90
- ONFO $133.59
- Revenue Next Year
- RDHL $82.69
- ONFO N/A
- P/E Ratio
- RDHL N/A
- ONFO N/A
- Revenue Growth
- RDHL N/A
- ONFO 29.25
- 52 Week Low
- RDHL $2.40
- ONFO $0.39
- 52 Week High
- RDHL $20.28
- ONFO $1.88
- Technical
- Relative Strength Index (RSI)
- RDHL 26.68
- ONFO 40.53
- Support Level
- RDHL $2.64
- ONFO $0.61
- Resistance Level
- RDHL $2.90
- ONFO $1.38
- Average True Range (ATR)
- RDHL 0.23
- ONFO 0.11
- MACD
- RDHL 0.07
- ONFO -0.03
- Stochastic Oscillator
- RDHL 6.76
- ONFO 41.34
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place.